Nama's AI scorecard currently rates Diebold Nixdorf Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is DBD's P/E ratio?

Diebold Nixdorf trades at a trailing price-to-earnings ratio of 9.9.

When does DBD report earnings?

Diebold Nixdorf's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $1.60.

What is the DBD price target?

The median analyst price target from 3 analysts is $85.00, with a range of $80.00 – $90.00.

Is DBD Shariah compliant?

Nama's AAOIFI-style screen reads Diebold Nixdorf as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

Diebold Nixdorf (DBD)

Technology · Software Application · NYSE

Diebold Nixdorf (DBD) is a Technology company in the Software Application industry. It has a market capitalization of $1.96B, a trailing price-to-earnings ratio of 9.9 and a free-cash-flow yield of 11.0%. Over the most recent reported fiscal year, revenue grew 1.5% and free cash flow per share grew 122.0%. Nama's AI scorecard rates it Hold, 5.6 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Hold · 5.6/10

The sections balance. As of Nov 7, 2026.

Momentum

Lagging · -0.8% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-36.7%

How far the last close sits under the highest price of the past five years.

Market cap	$1.96B
Trailing P/E	9.9
Price / book	2.1
Price / sales	0.5
FCF yield	11.0%
Dividend yield	—
Gross margin	25.0%
Operating margin	6.8%
Net margin	2.0%
Revenue growth (YoY)	+1.5%
Revenue growth (3-yr annual)	—
EPS growth (YoY)	+19.0%
FCF/share growth (YoY)	+122.0%
Beta	1.2
Exchange	NYSE
Sector	Technology
Industry	Software Application

DBD earnings

Next report: Feb 11, 2027 (Q4 2026, EPS estimate $1.60). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 28, 2026	$1.34	$1.31	+2.3%	$994.30M
Q2 2026	Jul 29, 2026	$1.10	$1.10	+0.0%	$930.80M
Q1 2026	Apr 30, 2026	$0.67	$0.62	+8.1%	$891.80M
Q4 2025	Feb 12, 2026	$2.75	$1.65	+66.7%	$1.10B

DBD analyst price target

Median target $85.00 from 3 analysts, ranging $80.00 – $90.00.

Software Application peers

Ticker	Company	Market cap	P/E
SAP	SAP	$269.45B	29.7
SHOP	Shopify	$191.58B	85.1
CRM	Salesforce	$175.83B	12.7
UBER	Uber Technologies	$140.05B	40.6
ADP	Automatic Data Processing	$119.75B	26.5
NOW	ServiceNow	$105.84B	26.9
SNOW	Snowflake	$97.33B	195.7
ADBE	Adobe	$93.14B	10.1

Explore live DBD data on Nama Insights →

DBD FAQ

Is DBD a buy?: Nama's AI scorecard currently rates Diebold Nixdorf Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is DBD's P/E ratio?: Diebold Nixdorf trades at a trailing price-to-earnings ratio of 9.9.
When does DBD report earnings?: Diebold Nixdorf's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $1.60.
What is the DBD price target?: The median analyst price target from 3 analysts is $85.00, with a range of $80.00 – $90.00.
Is DBD Shariah compliant?: Nama's AAOIFI-style screen reads Diebold Nixdorf as Not Shariah Compliant. At least one of the three ratios or the industry test failed.